SEC Form 4 · accession 0001500814-17-000005
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Saban
Officer — President
Period of report
Nov 20, 2017
Accepted (ET)
Nov 20, 2017 · 3:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 20, 2017 | P | 10,000 | $15.2433 | A | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $15.24 to $15.2499 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.